Published
October 5, 2025
Updated
August 4, 2026
Creditor voting ended in 2025, the bankruptcy court approved Purdue Pharma's roughly $7.4 billion reorganization plan, and the company was sentenced and dissolved in 2026.
What Is the Current Purdue Opioid Settlement Status?
The voting instructions in the original version of this article are obsolete. Creditor voting closed on September 30, 2025, and the bankruptcy court approved Purdue Pharma's roughly $7.4 billion reorganization plan in November 2025.In April 2026, a federal court sentenced Purdue on its earlier criminal fraud and kickback conspiracy pleas. The company was dissolved, with its successor structure and settlement funding governed by the approved bankruptcy plan.
Status
Plan approved
Bankruptcy approval entered November 2025
Plan Value
Approximately $7.4 billion
Paid across creditor groups over time
Voting
Closed
September 30, 2025 deadline passed
Why Was a New Plan Required?
The Supreme Court rejected Purdue's earlier bankruptcy plan in 2024 because it included nonconsensual releases protecting the Sackler family from opioid-related civil claims. Negotiations produced a revised plan supported by participating governments and creditor groups.What Does the Approved Plan Provide?
The plan combines Sackler family contributions, Purdue assets, and other value for states, local governments, tribes, personal-injury claimants, and other creditors. Much of the governmental recovery is designated for opioid-abatement programs. Payments and timing vary by creditor group and plan terms.Can New Personal-Injury Claims Be Filed?
The bankruptcy process used earlier bar dates for personal-injury claims. Approval of the plan did not create a new public claim period for people who missed those deadlines. Claimants should rely on official bankruptcy notices and the claims agent for their particular claim status.What Happened to Purdue Pharma?
The Justice Department announced in April 2026 that Purdue was sentenced for fraud and kickback conspiracies after its 2020 guilty plea. Purdue was ordered dissolved, and the successor entity contemplated by the restructuring is intended to operate for public benefit under the plan.Sources
• Official Purdue Pharma restructuring and court-document site• U.S. Justice Department sentencing announcement, April 2026
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
For more class actions keep scrolling below.
Status
Reorganization plan approved
Plan Value
Approximately $7.4 billion
Voting Deadline
September 30, 2025 (passed)
Approval
November 2025
Official Docket
Purdue restructuring site
